T Do

469 total citations
8 papers, 188 citations indexed

About

T Do is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, T Do has authored 8 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Radiology, Nuclear Medicine and Imaging, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in T Do's work include Radiopharmaceutical Chemistry and Applications (3 papers), Prostate Cancer Diagnosis and Treatment (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). T Do is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Prostate Cancer Diagnosis and Treatment (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). T Do collaborates with scholars based in United States and Denmark. T Do's co-authors include Lisa Tran, J. David Beatty, Robert A. Parker, Messoud Ashina, A. Robert Kagan, Raymond J. Paxton, M. Frederick Hawthorne, J E Shively, Lawrence E. Williams and Barbara Beatty and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, American Journal of Pharmaceutical Education and Revue Neurologique.

In The Last Decade

T Do

7 papers receiving 182 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Do United States 7 88 57 46 46 34 8 188
Peter Vavassis Canada 7 79 0.9× 27 0.5× 58 1.3× 63 1.4× 10 0.3× 21 170
Makbule Tambaş Türkiye 8 103 1.2× 41 0.7× 40 0.9× 110 2.4× 23 0.7× 26 297
Deepa Joseph India 8 59 0.7× 24 0.4× 44 1.0× 45 1.0× 5 0.1× 53 207
R.G.H.M. Cremers Netherlands 8 142 1.6× 11 0.2× 15 0.3× 37 0.8× 10 0.3× 16 222
Franz Herrmann Germany 4 96 1.1× 169 3.0× 170 3.7× 16 0.3× 24 0.7× 7 262
Carole Massabeau France 9 56 0.6× 15 0.3× 40 0.9× 78 1.7× 14 0.4× 32 196
Mariacarla Valli Switzerland 10 85 1.0× 23 0.4× 60 1.3× 71 1.5× 5 0.1× 23 196
Archi Agarwal India 6 198 2.3× 8 0.1× 41 0.9× 14 0.3× 8 0.2× 15 260
Ralph McCready United Kingdom 6 31 0.4× 53 0.9× 69 1.5× 14 0.3× 3 0.1× 8 125
Nathalie Mesgouez‐Nebout France 7 87 1.0× 30 0.5× 25 0.5× 16 0.3× 12 0.4× 15 306

Countries citing papers authored by T Do

Since Specialization
Citations

This map shows the geographic impact of T Do's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Do with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Do more than expected).

Fields of papers citing papers by T Do

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Do. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Do. The network helps show where T Do may publish in the future.

Co-authorship network of co-authors of T Do

This figure shows the co-authorship network connecting the top 25 collaborators of T Do. A scholar is included among the top collaborators of T Do based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Do. T Do is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Do, T, et al.. (2023). In Vitro Drug Metabolism and Pharmacokinetic Evaluation of Ent-Verticilide. American Journal of Pharmaceutical Education. 87(8). 100153–100153.
2.
Do, T, et al.. (2021). Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants. Revue Neurologique. 177(7). 827–833. 12 indexed citations
3.
Do, T, et al.. (2005). Metaplastic carcinoma of the breast: A retrospective review. International Journal of Radiation Oncology*Biology*Physics. 64(3). 771–775. 53 indexed citations
4.
Do, T, et al.. (2001). Serum PSA Evaluations during salvage radiotherapy for post-prostatectomy biochemical failures as prognosticators for treatment outcomes. International Journal of Radiation Oncology*Biology*Physics. 50(5). 1220–1225. 16 indexed citations
5.
Do, T, et al.. (1998). Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy.. PubMed. 4(5). 324–30. 62 indexed citations
6.
Beatty, Barbara, Raymond J. Paxton, M. Frederick Hawthorne, et al.. (1993). Pharmacokinetics of an anti-carcinoembryonic antigen monoclonal antibody conjugated to a bifunctional transition metal carborane complex (venus flytrap cluster) in tumor-bearing mice.. PubMed. 34(8). 1294–302. 6 indexed citations
7.
Beatty, J. David, et al.. (1990). Mechanisms of tissue uptake and metabolism of radiolabeled antibody--role of antigen: antibody complex formation.. PubMed. 50(3 Suppl). 840s–845s. 25 indexed citations
8.
Do, T, et al.. (1990). Mechanism of decreasing liver uptake of 111In-labeled anti-carcinoembryonic antigen monoclonal antibody by specific antibody pretreatment in tumor bearing mice.. PubMed. 50(3 Suppl). 846s–851s. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026